MedPath

AURO-NEVIRAPINE

AURO-NEVIRAPINE

Approved
DIN Number

02318601

Drug Class

Human

Market Date

Dec 29, 2010

Company
HC

auro pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02318601
AIG Number0134602001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AG01 NEVIRAPINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

NEVIRAPINEActive
Strength: 200 MG
Monograph: NEVIRAPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.